CeriBell: 3 Key Takeaways for Long-Term Investors

Source Motley_fool

Key Points

  • Full-year 2026 revenue guidance rose to $115 million to $117 million.

  • CeriBell expanded its active account base by 35 hospital accounts.

  • Third-quarter gross margin expanded to 90% from 88% last year.

  • Motley Fool Issues Rare "Total Conviction" Buy Alert ›

On its third-quarter 2026 earnings call, held on Nov. 3, 2026, CeriBell (NASDAQ:CBLL) announced full-year 2026 revenue guidance of $115 million to $117 million as usage per account reached post-IPO highs. Gross margins of 90% and expanding hardware capabilities provide operating leverage as the business moves into untapped market opportunities like delirium monitoring.

Three key takeaways from management stand out for long-term shareholders.

1. Delirium Upgrade Strategy Drives Headband Utilization Without Subscription Friction

CeriBell is launching its delirium monitoring tool as a fee-free software update to accelerate hospital adoption. Instead of charging extra subscription fees, management requires hospitals to train bedside staff, driving revenue through increased usage of single-use headbands.

As we move into commercial launch, we are offering our delirium monitoring solution as a software upgrade to CeriBell customers at no incremental increase to the subscription fee.
-- Jane Chao, Co-Founder and Chief Executive Officer

2. Omni Platform Unifies Point-of-Care Speed with Conventional Brain Monitoring

Management unveiled Omni, a hardware platform designed to merge quick bedside electroencephalogram (EEG) brain monitoring with traditional multi-day continuous recording. This expansion targets full hospital deployment by supporting eight Food and Drug Administration (FDA) cleared algorithms on a single device.

For the first time ever, hospitals can access the speed of point-of-care EEG while maintaining the comprehensiveness of conventional EEG, enhanced by our 8 FDA-cleared algorithms that monitor the brain for seizure, status epilepticus, delirium and other brain stress indicators, all in one platform, Omni.
-- Jane Chao, Co-Founder and Chief Executive Officer

3. High Gross Margins Protect the Path to Cash Flow Breakeven

Gross margin reached 90% in the quarter while cash reserves stood at $117.5 million. High margins allow the company to fund commercial investments and research while steering toward self-funded profitability.

We remain committed to our objective of achieving cash flow breakeven with cash on hand and the strength of our balance sheet and strong gross margin profile give us a high degree of confidence in our ability to do so.
-- Scott Blumberg, Chief Financial Officer

Looking Ahead

Commercial expansion into regional health systems and government networks like the Department of Veterans Affairs (VA) provides steady adoption tailwinds. A gross margin profile in the high 80% range and proprietary algorithm updates give CeriBell a defensible position as it scales across intensive care units.

We have less than 4% penetration in our core seizure market, which tells you how much runway is still ahead of us.
-- Jane Chao, Co-Founder and Chief Executive Officer

Management prioritizes commercial execution and usage discipline over price increases as it transitions pilots into full commercial launches across 2027.

Seizure detection will act as a durable base business. Both account acquisition and utilization are growing independently, compounding each other.
-- Jane Chao, Co-Founder and Chief Executive Officer

Should you buy stock in CeriBell right now?

Before you buy stock in CeriBell, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and CeriBell wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $305,941!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $771,325!*

Now, it’s worth noting Stock Advisor’s total average return is 719% — a market-crushing outperformance compared to 192% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of November 22, 2026.

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold Price Today: Can XAU/USD Hold $3,500? | Mitrade AUGold approaches US$3,500 as Fed tightening fears drive sharp weekly losses. Explore XAU/USD levels, Treasury yields and the outlook for Australian traders.
Author  Mitrade Team
Nov 20, Fri
Gold approaches US$3,500 as Fed tightening fears drive sharp weekly losses. Explore XAU/USD levels, Treasury yields and the outlook for Australian traders.
placeholder
Australia’s jobs market just cracked — has the AUD/USD rate story flipped?Australia’s weakening jobs market is raising fresh questions about the RBA’s interest rate outlook and the Australian dollar. Explore why AUD/USD could be losing support, the key factors driving currency movements and what Australian forex traders should watch next.
Author  Mark Garro
Nov 20, Fri
Australia’s weakening jobs market is raising fresh questions about the RBA’s interest rate outlook and the Australian dollar. Explore why AUD/USD could be losing support, the key factors driving currency movements and what Australian forex traders should watch next.
placeholder
Market News Today Australia: VIX Surges Nearly 16%, Gold Breaks US$3,600 and US Stocks SlideVIX jumps 15.8%, Nasdaq 100 falls 2.21% and gold slips below US$3,600. Explore Anthropic’s debut and the outlook for Australian CFD traders.
Author  Mitrade Team
Nov 20, Fri
VIX jumps 15.8%, Nasdaq 100 falls 2.21% and gold slips below US$3,600. Explore Anthropic’s debut and the outlook for Australian CFD traders.
placeholder
Is Tech in a Bear Market? 20 Tech Stocks Fall Up to 76% From HighsAll 20 tech stocks on a list from financial newsletter The Kobeissi Letter trade at least 25% below record highs. CoreWeave (CRWV) leads the slide at 76%.Additionally, the S&P 500 has lost over $6 tri
Author  Beincrypto
Nov 20, Fri
All 20 tech stocks on a list from financial newsletter The Kobeissi Letter trade at least 25% below record highs. CoreWeave (CRWV) leads the slide at 76%.Additionally, the S&P 500 has lost over $6 tri
placeholder
Gold and Bitcoin Are Falling. Peter Schiff Sees Opportunities for BothPeter Schiff says gold should not have fallen at all, while Bitcoin (BTC) has not fallen enough. The gold advocate calls the metal’s drop a buying opportunity and Bitcoin’s a selling opportunity.Both
Author  Beincrypto
Nov 20, Fri
Peter Schiff says gold should not have fallen at all, while Bitcoin (BTC) has not fallen enough. The gold advocate calls the metal’s drop a buying opportunity and Bitcoin’s a selling opportunity.Both
goTop
quote